Understanding the Clinical Scenario
The client is receiving lorazepam, a benzodiazepine, for anxiety. While therapeutic effects include anxiolysis and mild sedation, benzodiazepines also carry significant risks, particularly central nervous system (CNS) depression. The nurse must differentiate between an expected therapeutic response and a sign of toxicity or an adverse reaction that requires immediate intervention. According to evidence-based strategies for rational benzodiazepine use, these agents are recommended primarily for short-term management due to their safety profile concerns, which include sedation, cognitive impairment, and the potential for dependence
[4].
Analysis of Assessment Findings
When prioritizing nursing concerns, the airway, breathing, and circulation (ABC) framework combined with an assessment of neurological status guides decision-making. A change in level of consciousness or the emergence of new neurological symptoms signals a potentially life-threatening situation that takes precedence over other findings.
-
Option 1: Client reports feeling drowsy and relaxed. Drowsiness and relaxation are common, expected effects of lorazepam, which acts as a CNS depressant by potentiating the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). This finding, while requiring monitoring for progression, does not represent an immediate threat to safety.
-
Option 2: Client is confused, disoriented, and has slurred speech. This cluster of symptoms represents an acute change in mental status and neurological function. Confusion and disorientation are hallmark features of delirium, a serious condition that is frequent in vulnerable populations such as older adults . Slurred speech (dysarthria) indicates a significant level of CNS depression that can rapidly progress to respiratory compromise. This is a paradoxical or toxic reaction that constitutes the priority concern.
-
Option 3: Client states they feel less anxious than before. This is the desired therapeutic outcome of lorazepam administration. A reduction in anxiety confirms the medication is achieving its intended effect and requires no immediate intervention beyond routine monitoring.
-
Option 4: Blood pressure decreased from 140/90 to 120/80 mmHg. A modest reduction in blood pressure can occur with benzodiazepine-induced anxiolysis and sedation, as sympathetic nervous system activity decreases. With a reading of
120/80 mmHg, the client remains normotensive. This is a non-critical finding that does not indicate hemodynamic instability.
Pathophysiology and Clinical Reasoning for the Priority Concern
The priority finding is the sudden onset of confusion, disorientation, and slurred speech. This presentation is consistent with a severe adverse drug reaction, specifically benzodiazepine-induced neurotoxicity, which manifests as an acute confusional state or delirium. The underlying mechanism involves excessive GABA-A receptor potentiation, leading to profound CNS depression that disrupts cognitive processing, orientation, and motor coordination. This is distinct from the simple sedation seen in Option 1. The pharmacological management of such acute neuropsychiatric presentations in emergency settings is a critical area of focus, as delirium is associated with serious clinical outcomes . Furthermore, while benzodiazepines are first-line agents for conditions like status epilepticus due to their rapid action , their overdose or idiosyncratic reaction can produce a clinical picture that mimics or precipitates a neurological emergency. The loss of airway-protective reflexes due to a depressed level of consciousness is the most immediate danger. The presentation of altered mental status with neurological deficits, such as slurred speech, requires the nurse to immediately hold the medication, assess vital signs and oxygen saturation, ensure airway patency, and notify the prescriber, as the client may require emergency supportive care similar to the management of severe psychotropic medication poisoning .
The nurse’s immediate intervention is driven by the risk of respiratory depression and airway compromise, which directly threatens the client’s survival. This neurological deterioration is the clearest signal of a serious adverse event that must be addressed before any other non-critical finding.
References (research sources)